Immune checkpoint blockade in renal cell carcinoma (Record no. 76721)

000 -LEADER
fixed length control field 02536ngm a2200577 a 4500
001 - CONTROL NUMBER
control field HST4211
003 - CONTROL NUMBER IDENTIFIER
control field UkLoHST
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m c
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr|cna|||a||||
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field vz|czazum
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 160414s2016 enk|||||||||||s|||v|eng d
028 50 - PUBLISHER NUMBER
Publisher number 4211
Source Henry Stewart Talks
035 ## - SYSTEM CONTROL NUMBER
System control number (UkLoHST)3242
040 ## - CATALOGING SOURCE
Original cataloging agency UkLoHST
Language of cataloging eng
Transcribing agency UkLoHST
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name McDermott, David,
Affiliation (Harvard Medical School, USA)
Relator code spk
245 10 - TITLE STATEMENT
Title Immune checkpoint blockade in renal cell carcinoma
Medium [electronic resource] /
Statement of responsibility, etc. David McDermott.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. London :
Name of publisher, distributor, etc. Henry Stewart Talks,
Date of publication, distribution, etc. 2016.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (1 streaming video file (58 min.) :
Other physical details color, sound).
490 1# - SERIES STATEMENT
Series statement Immunotherapy of cancer,
International Standard Serial Number 2056-452X
490 1# - SERIES STATEMENT
Series statement The kidney in health and disease,
International Standard Serial Number 2056-452X
500 ## - GENERAL NOTE
General note Animated audio-visual presentation with synchronized narration.
500 ## - GENERAL NOTE
General note Title from title frames.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Contents: Recent data that has led to the approval of PD-1 blockade in RCC -- Approaches to patient selection -- Novel combination therapies that are entering pivotal trials.
506 ## - RESTRICTIONS ON ACCESS NOTE
Terms governing access Access restricted to subscribers.
538 ## - SYSTEM DETAILS NOTE
System details note Mode of access: World Wide Web.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Antineoplastic agents.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cancer
General subdivision Immunological aspects.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Immunotherapy.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Kidneys
General subdivision Cancer
-- Chemotherapy.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Kidneys
General subdivision Cancer
-- Immunological aspects.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Renal cell carcinoma.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Antibodies, Monoclonal
General subdivision therapeutic use.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Antineoplastic Agents
General subdivision therapeutic use.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Carcinoma, Renal Cell
General subdivision drug therapy.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Carcinoma, Renal Cell
General subdivision immunology.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cell Cycle Checkpoints.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Clinical Trials as Topic.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Combined Modality Therapy.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element CTLA-4 Antigen
General subdivision immunology.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Immunotherapy
General subdivision methods.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Kidney Neoplasms
General subdivision drug therapy.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Kidney Neoplasms
General subdivision immunology.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Patient Selection.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Programmed Cell Death 1 Receptor
General subdivision antagonists & inhibitors.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element T-Lymphocytes
General subdivision immunology.
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Henry Stewart talks.
Name of part/section of a work Biomedical & life sciences collection.
-- Immunotherapy of cancer.
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Henry Stewart talks.
Name of part/section of a work Biomedical & life sciences collection.
-- Kidney in health and disease.
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://hstalks.com/bs/3242/">https://hstalks.com/bs/3242/</a>
856 42 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://hstalks.com/bs/p/896/">https://hstalks.com/bs/p/896/</a>
Materials specified Series (Immunotherapy of cancer)
856 42 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://hstalks.com/bs/p/980/">https://hstalks.com/bs/p/980/</a>
Materials specified Series (Kidney in health and disease)

No items available.

Technical University of Mombasa
Tom Mboya Street, Tudor 90420-80100 , Mombasa Kenya
Tel: (254)41-2492222/3 Fax: 2490571